English
Views: 0
Diquat dichloride 42% TK is a technical concentrate used as an input for downstream formulation and registration work. A manufacturer evaluating this material must assess more than the nominal assay. Salt identity, counter-ion, water quality, impurity profile, analytical method, packaging, and the intended formulation route all affect whether a batch can move into development. This diquat dichloride 42% TK formulation checklist organizes those decisions in a sequence that can be documented for procurement, quality control, and regulatory review.
The first control is identity. Diquat is commonly supplied as a dibromide or dichloride salt, and the two forms must not be treated as interchangeable purchasing descriptions. A specification needs the complete chemical name, CAS reference, molecular form, active-moiety basis, and declared concentration basis. The Red Sun product page identifies diquat dichloride separately from other diquat products; a sourcing file should retain that identity evidence with the quotation and CoA.
“42% TK” requires clarification. TK is used in international pesticide trade to describe a technical concentrate or technical material supplied for further formulation. The percentage may be expressed on a product, active-ion, or active-moiety basis depending on the specification and jurisdiction. A buyer therefore needs a written statement of the assay basis. A number without a stated basis can create an apparent discrepancy between supplier documents and the registration dossier. The planned diquat dichloride 42% TK specification should preserve that basis in every controlled document.
· Record the chemical name, salt form, CAS reference, and molecular formula used by the supplier.
· State whether the 42% declaration is w/w and identify the active-moiety calculation.
· Match the identity on the CoA, SDS, label draft, import documents, and registration dossier.
· Require confirmation that the quoted material is not diquat dibromide or a blended concentrate.
A useful specification separates identity, content, physical properties, impurities, and storage performance. Assay is important, but it does not by itself establish formulation suitability. The specification should identify the analytical procedure, reporting units, sampling point, acceptance criteria, and treatment of results below a reporting limit. Where a method is proprietary, the supplier should provide enough method information for a receiving laboratory to verify selectivity and repeatability.
Physical description can also be relevant to handling. A technical concentrate may have defined appearance, density or relative density, pH, water content, and solubility behavior. Exact limits must come from the agreed specification and applicable reference standard; they should not be copied from a different diquat salt. A manufacturer can request representative data across commercial lots rather than relying on a single typical value.
FAO/WHO pesticide specifications provide a framework for evaluating pesticide products, but a generic framework does not automatically constitute a product registration specification in every market. The registration authority, approved label, and local quality standard remain controlling. This distinction is important when a technical concentrate will support more than one formulated product.
Each lot should arrive with a Certificate of Analysis that links the result to a batch number, manufacturing date, sample date, test date, and laboratory or quality unit. The document should show the method reference and units for assay and relevant impurities. A CoA that lists only “pass” provides limited evidence for a registration file or supplier qualification audit.
Analytical control normally includes an identity check and a quantitative assay suitable for the salt and matrix. Depending on the agreed specification, additional controls can include water, pH, density, insoluble matter, and identified or total impurities. The receiving laboratory should verify that the method distinguishes diquat dichloride from possible degradation products, related quaternary compounds, and the counter-ion contribution. Method-transfer records, chromatograms or spectra, reference-standard traceability, and system-suitability criteria make the result more defensible.
1. Document review: compare the CoA, SDS, purchase specification, and label terminology.
2. Identity confirmation: use an orthogonal identity approach where the risk assessment requires it.
3. Assay verification: test a defined number of incoming lots using a validated or verified method.
4. Impurity review: compare reported impurities with the registration data and toxicological assessment.
5. Trend control: monitor results over time instead of accepting isolated lots without a history.
Sampling must represent the shipment. Sealed containers, retain samples, chain-of-custody records, and defined quarantine release criteria reduce the risk that a compliant sample masks a non-uniform lot.
The downstream process determines which TK attributes matter most. A water-based soluble concentrate requires predictable dissolution, manageable foaming, and compatibility with co-formulants. A manufacturer evaluating a different formulation type must assess whether the technical material creates insoluble residues, excessive heat, viscosity changes, or filtration losses. These are development questions, not assumptions that can be answered from assay alone.
Small-scale trials should use representative process water and the intended order of addition. The study can record dissolution time, appearance, pH drift, sediment or precipitate formation, foam, filter differential pressure, and container compatibility. The record should identify the lot used, temperature range, mixing energy, and hold time. Such data help distinguish a raw-material issue from an equipment or process issue.
Formulation stability testing should cover the storage conditions and period required by the target registration. Accelerated studies can support development decisions, while real-time data may be required for the final shelf-life claim. Container-closure interaction, light exposure, freeze-thaw risk, and headspace should be considered when relevant. The result should be a defined release specification for the formulated product, not an unsupported assumption that all 42% TK lots will behave identically.
For safe handling, the SDS and local occupational controls govern operations. Diquat products are regulated differently across jurisdictions, and technical-material handling does not replace label compliance, engineering controls, or worker training.
Registration authorities generally need a coherent link between the technical material, manufacturing source, formulated product, intended uses, analytical methods, toxicology or ecotoxicology data, and proposed label. The dossier should identify the manufacturing site and critical process information required by the applicable jurisdiction. A change in source, salt form, impurity profile, or manufacturing route can trigger a data-gap assessment or change-control requirement.
The regulatory team should map each document to a dossier section before the first import or formulation campaign. Typical controls include the specification, batch analysis, five-batch or equivalent quality data where required, manufacturing description, impurity profile, SDS, packaging information, stability data, and certificates requested by the destination authority. The exact list varies by country and product type; current local requirements must be checked before submission.
The label should not imply uses, rates, crops, or safety statements that are absent from the approved registration. For restricted or controlled uses, the manufacturer should verify import permissions, licensed distribution, storage requirements, and applicator provisions in the target market. Regulatory status and product-label controls must be checked independently rather than inferred from a supplier quotation.
Packaging should protect the concentrate from leakage, contamination, and unacceptable exposure during storage and transport. The supply agreement should state container type, nominal fill, closure, tamper evidence, palletization, and required markings. The SDS and transport classification supplied for the actual product should be reviewed by qualified logistics personnel; classification must not be guessed from the active ingredient name alone.
Procurement and quality teams should agree on notification periods for changes in raw materials, manufacturing site, process, analytical method, container, or specification. A change-control clause allows the formulator to assess whether new comparative data, stability data, or regulatory notification is required. Retain samples and complaint procedures provide traceability if a formulated batch shows an unexpected color, precipitate, assay result, or stability trend.
Supplier qualification should combine technical evidence with operational evidence. The audit scope can include quality-system ownership, laboratory capability, batch traceability, deviation handling, complaint investigation, business continuity, and document control. A low price does not compensate for an incomplete impurity profile or an unstable supply chain when a registration depends on source-specific data.
A practical release decision uses three outcomes: approved, conditionally approved, or rejected. Approved status requires identity, specification, CoA, incoming verification, and dossier fit. Conditional approval can cover a development lot while a method-transfer or stability item remains open. Rejection is appropriate when salt identity is unclear, the assay basis cannot be reconciled, critical data are absent, or the SDS and transport documentation are inconsistent.
The following decision checklist can be retained in the purchasing file:
· Is the material demonstrably diquat dichloride rather than another salt?
· Is “42%” defined by a documented calculation and analytical method?
· Does the CoA include batch traceability, assay, impurities, and method references?
· Has the receiving laboratory verified representative lots?
· Has the intended formulation route passed compatibility and stability screening?
· Does the source fit the destination registration and change-control plan?
· Are packaging, SDS, transport, and storage controls complete for the shipment?
TK generally denotes a technical concentrate or technical material intended for further formulation. The exact definition and concentration basis should be stated in the commercial specification and checked against the destination authority’s terminology.
No automatic substitution is appropriate. Salt identity, assay basis, impurity profile, formulation behavior, registration data, and label status must be assessed separately.
Identity, assay with method and units, relevant impurities, batch traceability, physical description, and laboratory authorization are core items. Additional tests depend on the agreed specification and formulation route.
No. FAO/WHO specifications support quality assessment, while registration remains jurisdiction-specific and depends on the complete dossier, approved uses, risk assessment, and local label requirements.
The source should be placed under documented qualification, incoming verification, comparative quality review, and change control before routine commercial release.
A robust diquat dichloride 42% TK program links chemical identity to analytical control, formulation performance, registration evidence, logistics, and supplier governance. Manufacturers that document each link can make a defensible release decision and reduce avoidable rework during formulation or registration. Red Sun’s diquat dichloride technical material information can serve as a starting point for a source-specific technical review, while final specifications and regulatory decisions remain subject to applicable market requirements.
